151 related articles for article (PubMed ID: 24085226)
1. Significance of INHBA expression in human colorectal cancer.
Okano M; Yamamoto H; Ohkuma H; Kano Y; Kim H; Nishikawa S; Konno M; Kawamoto K; Haraguchi N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Sekimoto M; Doki Y; Mori M; Ishii H
Oncol Rep; 2013 Dec; 30(6):2903-8. PubMed ID: 24085226
[TBL] [Abstract][Full Text] [Related]
2. Relation of INHBA gene expression to outcomes in gastric cancer after curative surgery.
Oshima T; Yoshihara K; Aoyama T; Hasegawa S; Sato T; Yamamoto N; Akito N; Shiozawa M; Yoshikawa T; Numata K; Rino Y; Kunisaki C; Tanaka K; Akaike M; Imada T; Masuda M
Anticancer Res; 2014 May; 34(5):2303-9. PubMed ID: 24778035
[TBL] [Abstract][Full Text] [Related]
3. Inhibin, beta A regulates the transforming growth factor-beta pathway to promote malignant biological behaviour in colorectal cancer.
He Z; Liang J; Wang B
Cell Biochem Funct; 2021 Mar; 39(2):258-266. PubMed ID: 32662905
[TBL] [Abstract][Full Text] [Related]
4. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
6. The significance of PITX2 overexpression in human colorectal cancer.
Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Bcl-xL gene expression in human colorectal cancer.
Jin-Song Y; Zhao-Xia W; Cheng-Yu L; Xiao-Di L; Ming S; Yuan-Yuan G; Wei D
Acta Histochem; 2011 Dec; 113(8):810-4. PubMed ID: 21277008
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma.
Wu Z; Han X; Yan J; Pan Y; Gong J; Di J; Cheng Z; Jin Z; Wang Z; Zheng Q; Wang Y
Biomed Pharmacother; 2012 Jul; 66(5):373-7. PubMed ID: 22401929
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
10. Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.
Zeng L; Sun X
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984496
[No Abstract] [Full Text] [Related]
11. Discovery of PELATON links to the INHBA gene in the TGF-β pathway in colorectal cancer using a combination of bioinformatics and experimental investigations.
Abutalebi M; Li D; Ahmad W; Mokhtari K; Entezari M; Hashemi M; Fu J; Maghsoudloo M
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132239. PubMed ID: 38735606
[TBL] [Abstract][Full Text] [Related]
12. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
[TBL] [Abstract][Full Text] [Related]
13. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of
Katayama Y; Oshima T; Sakamaki K; Aoyama T; Sato T; Masudo K; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
In Vivo; 2017; 31(4):565-571. PubMed ID: 28652421
[TBL] [Abstract][Full Text] [Related]
15. Predicting lymph node metastasis in early colorectal cancer using the CITED1 expression.
Nasu T; Oku Y; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Tamura K; Ieda J; Yamamoto N; Takemura S; Nakamura Y; Yamaue H
J Surg Res; 2013 Nov; 185(1):136-42. PubMed ID: 23746764
[TBL] [Abstract][Full Text] [Related]
16. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
17. Expression of CLDN1 in colorectal cancer: a novel marker for prognosis.
Nakagawa S; Miyoshi N; Ishii H; Mimori K; Tanaka F; Sekimoto M; Doki Y; Mori M
Int J Oncol; 2011 Oct; 39(4):791-6. PubMed ID: 21720707
[TBL] [Abstract][Full Text] [Related]
18. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
19. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322
[TBL] [Abstract][Full Text] [Related]
20. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]